YW3-56 hydrochloride

YW3-56 hydrochloride 是一种 IC50 为 4.10 μM 的 PAD4 双功能抑制剂,在血液肿瘤中通过抑制 AKT/mTOR 信号轴诱导分化、凋亡 (apoptosis) 及代谢重编程,在实体瘤中则通过促进 DNA 损伤、诱导内质网应激和自噬 (autophagy) 障碍来抑制肿瘤生长并增敏放疗,可用于急性早幼粒细胞白血病、三阴性乳腺癌及鼻咽癌的相关研究。
产品编号: MS-F68106 CAS No.: 2309756-20-3 分子式: C27H33Cl2N5O2 分子量: 530.49
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

YW3-56 hydrochloride 是一种 IC50 为 4.10 μM 的 PAD4 双功能抑制剂,在血液肿瘤中通过抑制 AKT/mTOR 信号轴诱导分化、凋亡 (apoptosis) 及代谢重编程,在实体瘤中则通过促进 DNA 损伤、诱导内质网应激和自噬 (autophagy) 障碍来抑制肿瘤生长并增敏放疗,可用于急性早幼粒细胞白血病、三阴性乳腺癌及鼻咽癌的相关研究。

生物实验数据

生物活性 YW3-56 hydrochloride is a bifunctional PAD4 inhibitor with an IC50 of 4.10 μM that induces differentiation, apoptosis, and metabolic reprogramming in hematologic malignancies by inhibiting the AKT/mTOR signaling axis, while in solid tumors it inhibits tumor growth and sensitizes radiotherapy by promoting DNA damage and inducing endoplasmic reticulum stress and autophagy impairment, and it can be used for research on acute promyelocytic leukemia, triple-negative breast cancer, and nasopharyngeal carcinoma.
体外研究
(In Vitro)

YW3-56 (48 h) hydrochloride 可强效抑制 NB4 和 HL-60 细胞增殖,其 IC50 为 3.87 和 2.27 μM。
YW3-56 (4 μM; 48 h) hydrochloride 可显著降低 NB4 细胞中 H3Cit 的表达。
YW3-56 (2-8 μM) hydrochloride 可下调 AKT 的表达与磷酸化水平,并抑制 NB4 细胞中的 mTOR 信号通路,在 8 μM 时会出现 PI3K 的代偿性激活。
YW3-56 (2-8 μM; 24 h) hydrochloride 以剂量依赖的方式降低 NB4 细胞的存活率。
YW3-56 (2-8 μM; 24 h) hydrochloride 可在 NB4 细胞中诱导剂量依赖性的 caspase 介导的细胞凋亡,在 8 μM 时可观察到显著的晚期凋亡。
YW3-56 (2-8 μM; 24 h) hydrochloride 可降低 NB4 细胞中的干性标志物 (CD44、CD133),上调髓系分化标志物 (CD11b、CD14),并增强免疫原性激活标志物 (CD80、CD86) 的表达。
YW3-56 (4 μM; 5 days) hydrochloride 可诱导 NB4 细胞发生双向髓系分化 (粒细胞系和单核细胞系)。
YW3-56 (4 μM; 24 h) hydrochloride 可诱导 NB4 细胞发生代谢重编程,在转录后水平上主要抑制糖酵解并促进氧化代谢通路 (磷酸戊糖途径、三羧酸循环)。
YW3-56 (2-8 μM; 24 h) hydrochloride 可降低 NB4 细胞中 GLUT1 的表达水平及其膜定位。
YW3-56 (2-8 μM; 2 h) hydrochloride 可降低 NB4 细胞的葡萄糖摄取量。
YW3-56 (10 μM; 6 h) hydrochloride 可通过降低照射后的克隆形成存活率,增强 5-8F 和 C666-1 鼻咽癌细胞 (NPC 细胞) 的放射敏感性。
YW3-56 (10 μM; 12-30 h) hydrochloride 可在 6 Gy 照射后促进 5-8F 和 C666-1 鼻咽癌细胞 (NPC 细胞) 的 DNA 损伤,表现为 γ-H2AX 灶形成增加。
YW3-56 (10 μM; 6-30 h) hydrochloride 可在 6 Gy 辐照后增强并维持 5-8F 和 C666-1 鼻咽癌细胞中 γ-H2AX 蛋白的水平,该蛋白是 DNA 双链断裂的标志物。
YW3-56 (10 μM; 6-30 h) hydrochloride 可在 6 Gy 辐照后调控 5-8F 和 C666-1 鼻咽癌细胞 (NPC) 中凋亡相关蛋白的表达,上调促凋亡因子并下调抗凋亡因子。
YW3-56 (10 μM; 6-30 h) hydrochloride 可促进 5-8F 和 C666-1 鼻咽癌细胞的凋亡,且与 6 Gy 照射联合使用时该作用显著增强。
YW3-56 (10 μM; 6-30 h) hydrochloride 可诱导 5-8F 和 C666-1 鼻咽癌细胞发生 G0/G1 细胞周期阻滞,且与 6 Gy 辐照联合使用时该作用会增强。

Immunofluorescence

Cell Line: NB4 cells
Concentration: 4 μM
Incubation Time: 48 h
Result: Significantly reduced mean fluorescence intensity of H3Cit staining compared to control cells.
Effectively suppressed H3Cit expression.

Cell Viability Assay

Cell Line: NB4 cells
Concentration: 2-8 μM
Incubation Time: 24 h
Result: Induced concentration-dependent reductions in the proportion of viable NB4 cells.
Caused a progressive shift from viable (Calcein-AM+) to late apoptotic (PI+) populations.

Apoptosis Analysis

Cell Line: NB4 cells
Concentration: 2-8 μM
Incubation Time: 24 h
Result: Triggered a dose-dependent increase in apoptotic cells: early apoptotic cells increased from 2.14% (2 μM) to 5.73% (8 μM), while late apoptotic cells increased from 2.11% (2 μM) to 39.84% (8 μM).
Upregulated cleaved caspase-3 (5.5-fold) and cleaved PARP (3.8-fold) at 8 μM, confirmed via mass cytometry.

Cell Differentiation Assay

Cell Line: NB4 cells
Concentration: 4 μM
Incubation Time: 5 days
Result: Markedly increased both CD11b+ and CD14+ NB4 cells.
Indicated induction of granulocytic- and monocytic-like lineage differentiation.

Cell Proliferation Assay

Cell Line: 5-8F, C666-1 nasopharyngeal carcinoma (NPC) cells
Concentration: 10 μM
Incubation Time: 6 h
Result: Significantly reduced the clonogenic survival fraction of 5-8F and C666-1 cells in an irradiation dose-dependent manner, with a statistically significant difference observed at 8 Gy irradiation.

Immunofluorescence

Cell Line: 5-8F, C666-1 nasopharyngeal carcinoma (NPC) cells
Concentration: 10 μM
Incubation Time: 6 h, followed by 6 Gy irradiation and 24 h incubation
Result: Did not significantly change γ-H2AX foci number in the absence of irradiation.
Caused a significant increase in γ-H2AX foci number in both 5-8F and C666-1 cells after 6 Gy irradiation, indicating persistent DNA double-strand breaks.

Western Blot Analysis

Cell Line: 5-8F, C666-1 nasopharyngeal carcinoma (NPC) cells
Concentration: 10 μM
Incubation Time: 6 h, followed by 6 Gy irradiation and harvest at 0, 3, 12, 24 h post-irradiation
Result: Elevated the protein levels of γ-H2AX in 5-8F and C666-1 cells at multiple time points after 6 Gy irradiation, compared to untreated irradiated cells.\nIncreased the levels of pro-apoptotic proteins Bax, Bak, Bim, and Bad, and decreased the levels of anti-apoptotic proteins Bcl-2, Bcl-xl, and Mcl-1 in 5-8F and C666-1 cells following 6 Gy irradiation, compared to untreated irradiated cells.

Apoptosis Analysis

Cell Line: 5-8F, C666-1 nasopharyngeal carcinoma (NPC) cells
Concentration: 10 μM
Incubation Time: 6 h, followed by either no irradiation or 6 Gy irradiation and 24 h incubation
Result: Significantly increased apoptosis rates in both 5-8F and C666-1 cells when used alone.
Further significantly elevated apoptosis rates compared to irradiation alone when combined with 6 Gy irradiation, with apoptosis rates reaching ~30% in both cell lines.

Cell Cycle Analysis

Cell Line: 5-8F, C666-1 nasopharyngeal carcinoma (NPC) cells
Concentration: 10 μM
Incubation Time: 6 h, followed by either no irradiation or 6 Gy irradiation and 24 h incubation
Result: Caused G0/G1 phase arrest and reduced S and G2-M phase populations in 5-8F and C666-1 cells when used alone.
Further enhanced G0/G1 phase arrest compared to irradiation alone when combined with 6 Gy irradiation.
体内研究
(In Vivo)

YW3-56 (12.5-40 mg/kg;每日给药;腹腔注射;每 2 日给药 1 次;持续 26-32 天) hydrochloride 可显著抑制裸鼠体内三阴性乳腺癌异种移植物的生长。
YW3-56 (25 mg/kg;腹腔注射;每日一次;持续 35 天) hydrochloride 可在体内抑制鼻咽癌肿瘤生长,降低肿瘤重量。

Animal Model: nude mice (5-week-old)
Dosage: 12.5 mg/kg; 25 mg/kg; 40 mg/kg
Administration: i.p.; daily (12.5 mg/kg, 29 days); daily (25 mg/kg, 32 days); once every 2 days (40 mg/kg, 26 days)
Result: Observed significant growth inhibition in 4 of 6 tumors at 12.5 mg/kg, with responsive tumors showing SESN2 (5.4-83.2-fold), DDIT4 (3.9-19.8-fold), GADD45 (5.0-5.1-fold), PUMA (2.6-116.8-fold), and DDIT3 (1.8-63.7-fold) induction relative to PBS controls.
Observed significant tumor growth inhibition at 25 mg/kg.
Slowed growth in all 6 tumors at 40 mg/kg, with SESN2 (5.3-22.1-fold), DDIT4 (1.4-2.2-fold), GADD45 (1.1-13.2-fold), PUMA (5.1-23.9-fold), and DDIT3 (2.1-24.2-fold) induction relative to PBS controls.
Revealed fewer red blood cells and less fat tissue at the tumor surface via H&E staining of 40 mg/kg treated tumors.
Animal Model: BALB/C (5-week-old, weighing 20-23 g, subcutaneously injected with 5 × 106 C666-1 cells)
Dosage: 25 mg/kg
Administration: i.p.; daily; 35 days
Result: Significantly reduced tumor volume compared to control.
Significantly lowered tumor weight compared to control.
Decreased levels of p-PI3K, Bcl-2, Bcl-xl, and Mcl-1 in tumor tissues.
Increased levels of Bax, Bak, Bim, Bad, and cleaved caspase-3 in tumor tissues.
Enhanced tumor volume reduction effect when combined with 8 Gy irradiation.

化学信息

分子量 530.49
分子式 C27H33Cl2N5O2
CAS No. 2309756-20-3

储存&溶解度

溶解度信息
Methanol: 10 mg/mL (18.85 mM), Sonication is recommended.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础